Cargando…
Clinical evaluation of molecular surrogate subtypes in patients with ipsilateral multifocal primary breast cancer
BACKGROUND: When ipsilateral multifocal primary breast cancer (IMBC) is detected, standard routine is to evaluate the largest tumor with immunohistochemistry (IHC). As all foci are not routinely characterized, many patients may not receive optimal adjuvant treatment. Here, we assess the clinical rel...
Autores principales: | Janeva, Slavica, Krabbe, Ellen, Parris, Toshima Z., Nasic, Salmir, Sundquist, Marie, Karlsson, Per, Audisio, Riccardo A., Olofsson Bagge, Roger, Kovács, Anikó |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10080895/ https://www.ncbi.nlm.nih.gov/pubmed/37024949 http://dx.doi.org/10.1186/s13058-023-01632-5 |
Ejemplares similares
-
Comparison of breast cancer surrogate subtyping using a closed-system RT-qPCR breast cancer assay and immunohistochemistry on 100 core needle biopsies with matching surgical specimens
por: Janeva, Slavica, et al.
Publicado: (2021) -
Clinical relevance of biomarker discordance between primary breast cancers and synchronous axillary lymph node metastases
por: Janeva, Slavica, et al.
Publicado: (2023) -
Previously diagnosed multiple primary malignancies in patients with breast carcinoma in Western Sweden between 2007 and 2018
por: Nyqvist, Jenny, et al.
Publicado: (2020) -
Evaluation of intraoperative touch imprint cytology on axillary sentinel lymph nodes in invasive breast carcinomas, a retrospective study of 1227 patients comparing sensitivity in the different tumor subtypes
por: Pétursson, Hafsteinn Ingi, et al.
Publicado: (2018) -
Validation of Novel Prognostic Biomarkers for Early-Stage Clear-Cell, Endometrioid and Mucinous Ovarian Carcinomas Using Immunohistochemistry
por: Engqvist, Hanna, et al.
Publicado: (2020)